Literature DB >> 8826876

A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity.

D Ross, R D Traver, D Siegel, B L Kuehl, V Misra, A M Rauth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8826876      PMCID： PMC2074732          DOI： 10.1038/bjc.1996.477

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  10 in total

1.  Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking.

Authors:  E A Rosvold; K A McGlynn; E D Lustbader; K H Buetow
Journal:  Pharmacogenetics       Date:  1995-08

2.  Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells.

Authors:  D Siegel; N W Gibson; P C Preusch; D Ross
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

3.  Expression of NAD(P)H:quinone oxidoreductase and glutathione S-transferases alpha and pi in human renal cell carcinoma and in kidney cancer-derived cell lines.

Authors:  P Eickelmann; T Ebert; U Warskulat; W A Schulz; H Sies
Journal:  Carcinogenesis       Date:  1994-02       Impact factor: 4.944

4.  Loss of heterozygosity at the NAD(P)H: quinone oxidoreductase locus associated with increased resistance against mitomycin C in a human bladder carcinoma cell line.

Authors:  P Eickelmann; W A Schulz; D Rohde; B Schmitz-Dräger; H Sies
Journal:  Biol Chem Hoppe Seyler       Date:  1994-07

5.  NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.

Authors:  R D Traver; T Horikoshi; K D Danenberg; T H Stadlbauer; P V Danenberg; D Ross; N W Gibson
Journal:  Cancer Res       Date:  1992-02-15       Impact factor: 12.701

Review 6.  DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C.

Authors:  D Ross; D Siegel; H Beall; A S Prakash; R T Mulcahy; N W Gibson
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

7.  An alternatively spliced form of NQO1 (DT-diaphorase) messenger RNA lacking the putative quinone substrate binding site is present in human normal and tumor tissues.

Authors:  P Y Gasdaska; H Fisher; G Powis
Journal:  Cancer Res       Date:  1995-06-15       Impact factor: 12.701

8.  Detection of a point mutation in NQO1 (DT-diaphorase) in a patient with colon cancer.

Authors:  J M Kolesar; J G Kuhn; H A Burris
Journal:  J Natl Cancer Inst       Date:  1995-07-05       Impact factor: 13.506

Review 9.  Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies.

Authors:  D Ross; H Beall; R D Traver; D Siegel; R M Phillips; N W Gibson
Journal:  Oncol Res       Date:  1994       Impact factor: 5.574

10.  Presence of a heterozygous substitution and its relationship to DT-diaphorase activity.

Authors:  B L Kuehl; J W Paterson; J W Peacock; M C Paterson; A M Rauth
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640
  10 in total
  17 in total

1.  Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.

Authors:  Ho-Cheol Kim; Joon Seon Song; Jae Cheol Lee; Dae Ho Lee; Sang-We Kim; Jung-Shin Lee; Woo Sung Kim; Jin Kyung Rho; Sun Ye Kim; Chang-Min Choi
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

2.  High throughput genotyping for the detection of a single nucleotide polymorphism in NAD(P)H quinone oxidoreductase (DT diaphorase) using TaqMan probes.

Authors:  M M Shi; S P Myrand; M R Bleavins; F A de la Iglesia
Journal:  Mol Pathol       Date:  1999-10

3.  Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma.

Authors:  Toshifumi Wakai; Yoshio Shirai; Jun Sakata; Yasunobu Matsuda; Pavel V Korita; Masaaki Takamura; Yoichi Ajioka; Katsuyoshi Hatakeyama
Journal:  Int J Clin Exp Pathol       Date:  2011-04-10

4.  A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity.

Authors:  J L Moran; D Siegel; D Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

5.  NQO1 stabilizes p53 through a distinct pathway.

Authors:  Gad Asher; Joseph Lotem; Rachel Kama; Leo Sachs; Yosef Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

6.  The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancer.

Authors:  Jill M Kolesar; Suzanne E Dahlberg; Sharon Marsh; Howard L McLeod; David H Johnson; Steven M Keller; Joan H Schiller
Journal:  Oncol Rep       Date:  2011-04-06       Impact factor: 3.906

7.  Glutathione S-transferases deletions may act as prognosis and therapeutic markers in breast cancer.

Authors:  Clodoaldo Zago Campos; Roberta Losi Guembarovski; Carlos Eduardo Coral de Oliveira; Bruna Karina Banin Hirata; Glauco Akelinghton Freire Vitiello; Flávia Luísa Dias; Carlos Hiroji Hiroki; Maria Angelica Ehara Watanabe; Tânia Longo Mazzuco
Journal:  Clin Exp Med       Date:  2017-04-28       Impact factor: 3.984

8.  Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.

Authors:  Ji-Yeob Choi; William E Barlow; Kathy S Albain; Chi-Chen Hong; Javier G Blanco; Robert B Livingston; Warren Davis; James M Rae; I-Tien Yeh; Laura F Hutchins; Peter M Ravdin; Silvana Martino; Alan P Lyss; C Kent Osborne; Martin D Abeloff; Daniel F Hayes; Christine B Ambrosone
Journal:  Clin Cancer Res       Date:  2009-08-11       Impact factor: 12.531

9.  Genetic polymorphisms in glutathione S-transferase T1 affect the surgical outcome of varicocelectomies in infertile patients.

Authors:  Kentaro Ichioka; Kanji Nagahama; Kazutoshi Okubo; Takeshi Soda; Osamu Ogawa; Hiroyuki Nishiyama
Journal:  Asian J Androl       Date:  2009-01-19       Impact factor: 3.285

10.  Benzene metabolite hydroquinone up-regulates chondromodulin-I and inhibits tube formation in human bone marrow endothelial cells.

Authors:  Hongfei Zhou; Jadwiga K Kepa; David Siegel; Shigenori Miura; Yuji Hiraki; David Ross
Journal:  Mol Pharmacol       Date:  2009-06-12       Impact factor: 4.436
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.